Pharvaris
(NASDAQ) PHVS
Pharvaris Financials at a Glance
Market Cap
$2.33B
Revenue (TTM)
€0.00
Net Income (TTM)
-€169.20M
EPS (TTM)
-$3.18
P/E Ratio
-10.48
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Price
$34.01
Volume
28,660
Open
$33.88
Price
$34.01
Volume
28,660
Open
$33.88
Previous Close
$34.01
Daily Range
$32.97 - $34.02
52-Week Range
$16.72 - $35.33
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Price
$34.01
Volume
28,660
Open
$33.88
Previous Close
$34.01
Daily Range
$32.97 - $34.02
52-Week Range
$16.72 - $35.33
Estimated Earnings Date
Aug 11, 2026
PHVS News
PHVS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pharvaris
Industry
Pharmaceuticals
Sector
Health CareEmployees
129
CEO
Berndt A. E. Modig, MBA, CPA
Website
www.pharvaris.comHeadquarters
Leiden, ZH 6300, NL
PHVS Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-67.40%
Return on Capital
-62.42%
Return on Assets
-65.13%
Earnings Yield
-9.54%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.33B
Shares Outstanding
69.86M
Volume
28.66K
Avg. Volume
333.64K
Financials (TTM)
Gross Profit
-€106.45K
Operating Income
-€172.64M
EBITDA
-€166.73M
Operating Cash Flow
-€148.17M
Capital Expenditure
-€56.57K
Free Cash Flow
-€148.23M
Cash & ST Invst.
€246.96M
Total Debt
€738.89K
Pharvaris Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
€0.00
N/A
Gross Profit
-€106.45K
N/A
Gross Margin
0.00%
N/A
Market Cap
$2.33B
N/A
Market Cap/Employee
$18.03M
N/A
Employees
129
N/A
Net Income
-€39.85M
+14.0%
EBITDA
-€39.37M
+6.4%
Quarterly Fundamentals
Total Cash
€246.96M
+4.4%
Total Debt
€738.89K
-0.3%
Accounts Receivable
€4.98M
+88.2%
Inventory
€0.00
N/A
Long Term Debt
€532.58K
-2.5%
Short Term Debt
€206.31K
+6.0%
Return on Assets
-65.13%
N/A
Return on Invested Capital
-72.88%
N/A
Free Cash Flow
-€49.62M
-28.4%
Operating Cash Flow
-€49.57M
-28.8%